A Short Biography of Benjamin Graham
Benjamin Graham is considered the godfather of value investing. Understanding his system and his thinking can help you find the right value stocks.
Read More
Benjamin Graham is considered the godfather of value investing. Understanding his system and his thinking can help you find the right value stocks.
Read More
Our second recommendation is a short that is failing technical tests.
Read More
Our first idea today is picking up steam due to its coronavirus testing; the company just walloped analysts’ projections for its third quarter.
Read More
Our second recommendation is a short sale of a company that is being weighed down by COVID-19.
Read More
Since its $0.06 earnings beat, our first idea today—a restaurant chain—has seen its earnings estimates upgraded by 31 analysts.
Read More
As the market continues its improbable rally, new leaders are emerging. Salesforce.com stock and Quanta Services look particularly attractive.
Read More
Which stocks have been doing best in this volatile year? Here are the 5 top mid-year stock picks identified from 200+ expert analysts’ choices for 2020.
Read More
This electric car company is expected to grow by triple-digits next year.
Read More
In Cabot's 50 years, we've only been fooled three times by financial frauds, including Luckin Coffee stock. But you can still profit from these frauds.
Read More
My first stock market crash occurred in 1987, when the Dow fell 22.8% in one day. How we helped Cabot readers get through that crash can help you now.
Read More
Cabot Wealth Network turns 50 this year! This is the story of how Cabot came to be - and how we're still making money for our readers five decades later.
Read More
Our second recommendation is a short sale of a stock that is facing increasing competition.
Read More
Our first idea today is a medical device company who recently saw coverage of its shares initiated at Roth Capital with a ‘Buy’ rating.
Read More
This electric car company earned $1.86 per share in its latest quarter, surprising Wall Street and analysts who had forecasted -$.42.
Read More
This company continues to spin off and acquire other businesses, strengthening its medical and commercial strategy.
Read More
Earnings for this social media site were recently raised by 34%, and the company is forecasted to grow at an annual rate of 67.4% over the next five years.
Read More
11 analysts have raised their EPS estimates for this investment banking firm in the last 30 days.
Read More
This medical device company is due to report earnings on January 24, and recently reported that its revenue would be up about 17%, which is higher than analysts expected.
Read More
Analysts expect this chipmaker to grow 34.8% next year.
Read More
Analysts are forecast 25% annual growth for this construction aggregate company over the next five years.
Read More